Similar Articles
Use of Clozapine in the Treatment-Resistant Schizoprenia
Oğuzhan Kütük
DOI: 10.5606/jebms.2020.75609
Issue: 2020, Volume 1 - Issue 1
1227
1029
Glucagon-Like Peptide-1 and Psychiatric Disorder
Ayşe Şiva Acar, Oytun Erbaş
DOI: 10.5606/jebms.2021.75645
Issue: 2021, Volume 2 - Issue 2
2494
1706
Brain-Derived Neurotrophic Factor (BDNF) Polymorphism and Depression-Suicide
İlayda Üzümcü, Oytun Erbaş
DOI: 10.5606/jebms.2021.75654
Issue: 2021, Volume 2 - Issue 2
807
655
Synaptic Vesicle Protein 2A: Basic Facts and Roles in Schizophrenia
Aylin Kayaaltı, Berzah Güneş, Oytun Erbaş
DOI: 10.5606/jebms.2021.75677
Issue: 2021, Volume 2 - Issue 3
1419
544
The Impact of ALX Genes Expression Difference on Cancer
Simge Sevinç, Aslı Babayakalı, Oytun Erbaş
DOI: 10.5606/jebms.2021.75682
Issue: 2021, Volume 2 - Issue 3
861
640
Neuregulin 1 and Its Roles in Schizophrenia: A Systematic Review
Dildar Savcı, Sultan Karadeniz, Oytun Erbaş
DOI: 10.5606/jebms.2021.75683
Issue: 2021, Volume 2 - Issue 3
727
671
Gluten and Casein: Their Roles in Psychiatric Disorders
Ayşegül Şimal Ulaş, Arzu Çakır, , Oytun Erbaş
DOI: 10.5606/jebms.2022.1003
Issue: 2022, Volume 3 - Issue 1
6312
1602
Understanding the Role of DISC1 in Psychiatric Disorders
Şeyda Yazıcı, Hadi Sasani, Oytun Erbaş
DOI: 10.5606/jebms.2022.1011
Issue: 2022, Volume 3 - Issue 1
940
539
Association of NOS1AP Variants in Schizophrenia
Ayşenur Saygılı, Oytun Erbaş
DOI: 10.5606/jebms.2022.1013
Issue: 2022, Volume 3 - Issue 1
939
540
An Overview of Antipsychotics: Mechanisms of Action
Öznur Demirci, İrem Adar, Oytun Erbaş
DOI: 10.5606/jebms.2023.1047
Issue: 2023, Volume 4 - Issue 1
2264
1003